BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.00
-0.58%
After-hours: Aug 15, 2025, 07:58 PM EDT
BridgeBio Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 110.56M | 116.63M | 5.88M | 2.73M | 2.17M | 211.12M | 1.75M | 4.09M | 1.64M | 1.83M | 1.87M | 338K | 73.75M | 1.69M | 12.89M | 2.34M | 54.02M | 462K |
Cost of Revenue | 4.27M | 605K | 2.08M | 598K | 598K | 1.89M | 598K | 598K | 599K | 651K | 647K | 739K | 700K | 1.35M | 1.55M | 1.45M | 109K | n/a |
Gross Profit | 106.3M | 116.03M | 3.8M | 2.13M | 1.57M | 209.23M | 1.15M | 3.49M | 1.04M | 1.18M | 1.22M | -401K | 73.05M | 346K | 11.34M | 890K | 53.91M | 462K |
Operating Income | -133.47M | -104.37M | -226.03M | -191.75M | -175.54M | 3.74M | -177.42M | -157.69M | -146.1M | -126.16M | -122.19M | -129.12M | 26.12M | -151.02M | -165.61M | -149.5M | -94.02M | -167.5M |
Interest Income | 3.9M | 5.38M | 4.68M | 3.3M | 5.2M | 4.08M | 5.58M | 3.79M | 4.51M | 4.15M | 4.09M | 2.42M | 766K | 267K | 182K | 234K | 323K | 394K |
Pretax Income | -181.66M | -167.42M | -266.24M | -164.25M | -75.54M | -36.16M | -170.33M | -177M | -160.7M | -142.73M | -140.57M | -140.19M | -2.56M | -201.33M | -152.28M | -161.02M | -102.07M | -171.08M |
Net Income | -181.9M | -167.42M | -265.05M | -162.04M | -73.46M | -35.22M | -168.15M | -177M | -157.9M | -176.85M | -155.97M | -148.42M | 59.37M | -246.71M | -147.18M | -155.94M | -96.35M | -163.08M |
Selling & General & Admin | 128.54M | 106.36M | 94.78M | 68.82M | 59.52M | 64.51M | 47.58M | 35.78M | 36.12M | 31.11M | 31.86M | 31.19M | 36.43M | 43.71M | 54.75M | 46.08M | 45.97M | 45.41M |
Research & Development | 111.23M | 111.43M | 130.35M | 120.44M | 114.69M | 140.97M | 130.23M | 125.14M | 108.09M | 93.51M | 91.55M | 92.51M | 108.4M | 107.65M | 123.75M | 104.31M | 102.07M | 122.56M |
Other Expenses | n/a | 2.6M | 4.69M | 4.62M | 2.89M | n/a | n/a | 272K | n/a | -601K | n/a | n/a | n/a | n/a | n/a | -684K | n/a | n/a |
Operating Expenses | 239.77M | 220.4M | 229.82M | 193.88M | 177.11M | 205.48M | 177.81M | 161.19M | 144.21M | 124.62M | 123.41M | 123.7M | 144.83M | 151.36M | 178.5M | 150.39M | 148.04M | 167.97M |
Interest Expense | 37.64M | 42.14M | 29.82M | 23.06M | 22.94M | 23.47M | 20.27M | 20.31M | 20.59M | 20.12M | 19.99M | 19.82M | 20.28M | 20.34M | 15.13M | 11.07M | 10.84M | 9.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.34M | n/a | n/a | n/a |
Cost & Expenses | 244.04M | 221M | 231.91M | 194.48M | 177.71M | 207.38M | 178.41M | 161.78M | 144.21M | 124.62M | 123.41M | 124.44M | 145.53M | 152.71M | 178.5M | 151.84M | 148.04M | 167.97M |
Income Tax Expense | 2.1M | 2.19M | 1.15M | n/a | n/a | -944K | n/a | -1.64M | n/a | 34.11M | 15.4M | 8.22M | -61.92M | 45.38M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
Shares Outstanding (Diluted) | 190.52M | 190.15M | 189.44M | 188.51M | 187.59M | 178.71M | 174.46M | 163.31M | 160.54M | 152.65M | 149.34M | 147.94M | 146.68M | 145.88M | 145.28M | 146.66M | 146.75M | 138.63M |
EPS (Basic) | -0.95 | -0.88 | -1.4 | -0.86 | -0.39 | -0.2 | -0.96 | -1.08 | -0.98 | -1.16 | -1.04 | -1 | 0.40 | -1.69 | -1.01 | -1.06 | -0.66 | -1.18 |
EPS (Diluted) | -0.95 | -0.88 | -1.4 | -0.86 | -0.39 | -0.2 | -0.96 | -1.08 | -0.98 | -1.16 | -1.04 | -1 | 0.40 | -1.69 | -1.01 | -1.06 | -0.66 | -1.18 |
EBITDA | -142.7M | -126.18M | -235.05M | -139.66M | -51.03M | -11.09M | -148.47M | -157.54M | -138.47M | -120.98M | -118.92M | -118.72M | -70.2M | -179.1M | -137.17M | -149.68M | -88.55M | -159.98M |
EBIT | -144.02M | -127.47M | -236.41M | -141.19M | -52.61M | 3.74M | -150.06M | -159.18M | -140.11M | -122.61M | -120.58M | -120.37M | 17.72M | -180.99M | -138.7M | -149.95M | -91.23M | -161.34M |
Depreciation & Amortization | 1.32M | 1.28M | 1.37M | 1.54M | 1.57M | 1.6M | 1.58M | 1.64M | 1.64M | 1.63M | 1.66M | 1.65M | 1.58M | 1.88M | 1.53M | 265K | 2.69M | 1.36M |